Carson Wealth (CWM LLC)
NVCT icon

Carson Wealth (CWM LLC)’s Nuvectis Pharma NVCT Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.31K Buy
170
+137
+415% +$1.17K ﹤0.01% 5358
2025
Q4 		$0 Sell
33
-2
-6% -$13 ﹤0.01% 5548
2025
Q3 		$0 Buy
+35
New +$241 ﹤0.01% 5451
2024
Q3 		– Sell
-16
Closed – – 5044
2024
Q2 		$0 Buy
+16
New +$109 ﹤0.01% 4827

Other funds holding NVCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Carson Wealth (CWM LLC)'s NVCT Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Nuvectis Pharma (NVCT) stake by 415% in Q1 2026, buying an estimated $1.17K and bringing the position to 170 shares worth $1.31K. The position accounts for ﹤0.01% of the portfolio, ranked #5358.

Carson Wealth (CWM LLC) first reported a position in NVCT in Q2 2024 and has held it in 4 quarters since. 62 funds tracked by Wall St. Rank hold NVCT as of Q1 2026.

  • Carson Wealth (CWM LLC) held 170 shares of Nuvectis Pharma worth $1.31K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 137 Nuvectis Pharma shares in Q1 2026, an estimated $1.17K.
  • Nuvectis Pharma made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5358 holding.
  • Carson Wealth (CWM LLC) first reported a position in Nuvectis Pharma in Q2 2024 and has held it in 4 quarters since.
  • 62 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.